Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-12-03

AUTHORS

Jennifer Dotson, Adee Elhamdani, Ellen Petryna, Muhammad Omer Jamil, Mohamed Alsharedi

ABSTRACT

Neutropenic enterocolitis mostly affects patients with acute myeloid leukemia (AML) who get treated with intensive chemotherapy which is associated with prolonged neutropenia; its pathogenesis is not well understood and the main factors in this life-threatening condition appear to be neutropenia, mucosal injury and a weakened immune system as a consequence of intensive chemotherapeutic agents. Midostaurin in combination with chemotherapy became the standard of care for FLT3 mutant AML since its approval by the United States Food and Drug Administration (FDA) in April 2017. Anecdotally in our institution, we noticed the common occurrence of neutropenic colitis in three out of three patients who were treated with midostaurin as part of induction chemotherapy for AML. More... »

PAGES

351-355

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-018-2558-4

DOI

http://dx.doi.org/10.1007/s12185-018-2558-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110337576

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30506467


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enterocolitis, Neutropenic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Induction Chemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Staurosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fms-Like Tyrosine Kinase 3", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dotson", 
        "givenName": "Jennifer", 
        "id": "sg:person.01362136207.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362136207.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elhamdani", 
        "givenName": "Adee", 
        "id": "sg:person.012047320155.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012047320155.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petryna", 
        "givenName": "Ellen", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jamil", 
        "givenName": "Muhammad Omer", 
        "id": "sg:person.012156670311.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012156670311.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alsharedi", 
        "givenName": "Mohamed", 
        "id": "sg:person.01037220762.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037220762.97"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-12-03", 
    "datePublishedReg": "2018-12-03", 
    "description": "Neutropenic enterocolitis mostly affects patients with acute myeloid leukemia (AML) who get treated with intensive chemotherapy which is associated with prolonged neutropenia; its pathogenesis is not well understood and the main factors in this life-threatening condition appear to be neutropenia, mucosal injury and a weakened immune system as a consequence of intensive chemotherapeutic agents. Midostaurin in combination with chemotherapy became the standard of care for FLT3 mutant AML since its approval by the United States Food and Drug Administration (FDA) in April 2017. Anecdotally in our institution, we noticed the common occurrence of neutropenic colitis in three out of three patients who were treated with midostaurin as part of induction chemotherapy for AML.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12185-018-2558-4", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "109"
      }
    ], 
    "keywords": [
      "acute myeloid leukemia", 
      "neutropenic enterocolitis", 
      "induction chemotherapy", 
      "myeloid leukemia", 
      "FLT3-mutant acute myeloid leukemia", 
      "mutant acute myeloid leukemia", 
      "life-threatening condition", 
      "standard of care", 
      "United States Food", 
      "neutropenic colitis", 
      "intensive chemotherapy", 
      "mucosal injury", 
      "Drug Administration", 
      "chemotherapy", 
      "immune system", 
      "chemotherapeutic agents", 
      "patients", 
      "States Food", 
      "midostaurin", 
      "enterocolitis", 
      "neutropenia", 
      "leukemia", 
      "common occurrence", 
      "colitis", 
      "pathogenesis", 
      "injury", 
      "FLT3", 
      "administration", 
      "care", 
      "approval", 
      "agents", 
      "food", 
      "factors", 
      "occurrence", 
      "combination", 
      "consequences", 
      "institutions", 
      "standards", 
      "main factors", 
      "part", 
      "conditions", 
      "system"
    ], 
    "name": "Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin", 
    "pagination": "351-355", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110337576"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-018-2558-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30506467"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-018-2558-4", 
      "https://app.dimensions.ai/details/publication/pub.1110337576"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_774.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12185-018-2558-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-018-2558-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-018-2558-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-018-2558-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-018-2558-4'


 

This table displays all metadata directly associated to this object as RDF triples.

174 TRIPLES      20 PREDICATES      78 URIs      70 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-018-2558-4 schema:about N0ce2b6bad3184977be1b455336f9e7bb
2 N21aa443c199846018f8d813d7c582915
3 N6555dc42bbc5482dacbd561f553642ae
4 N689d811e42fc4bfd942ebec39714e70f
5 N7dc004d3e02c492ca675ccc0813e85b7
6 N81a2d03e967542b69213a8155c4cfcdd
7 N93a19fc33fcd47a9b7e7700388a71de6
8 Nc08a115a78ee4c238c49fb85cd874b97
9 Ndefcdf03031d427d8edf225456043505
10 Ne6d7f296e4f94d9da7ea64beb72bde9a
11 Nf8527d12c9bd42faae348c3989279745
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N762cbe382915437f8f9e75a529f757e8
15 schema:datePublished 2018-12-03
16 schema:datePublishedReg 2018-12-03
17 schema:description Neutropenic enterocolitis mostly affects patients with acute myeloid leukemia (AML) who get treated with intensive chemotherapy which is associated with prolonged neutropenia; its pathogenesis is not well understood and the main factors in this life-threatening condition appear to be neutropenia, mucosal injury and a weakened immune system as a consequence of intensive chemotherapeutic agents. Midostaurin in combination with chemotherapy became the standard of care for FLT3 mutant AML since its approval by the United States Food and Drug Administration (FDA) in April 2017. Anecdotally in our institution, we noticed the common occurrence of neutropenic colitis in three out of three patients who were treated with midostaurin as part of induction chemotherapy for AML.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N01fae2deaa54438682a0828a06dd9c47
21 N8edbab97901f4685a42b7eeb402452de
22 sg:journal.1076985
23 schema:keywords Drug Administration
24 FLT3
25 FLT3-mutant acute myeloid leukemia
26 States Food
27 United States Food
28 acute myeloid leukemia
29 administration
30 agents
31 approval
32 care
33 chemotherapeutic agents
34 chemotherapy
35 colitis
36 combination
37 common occurrence
38 conditions
39 consequences
40 enterocolitis
41 factors
42 food
43 immune system
44 induction chemotherapy
45 injury
46 institutions
47 intensive chemotherapy
48 leukemia
49 life-threatening condition
50 main factors
51 midostaurin
52 mucosal injury
53 mutant acute myeloid leukemia
54 myeloid leukemia
55 neutropenia
56 neutropenic colitis
57 neutropenic enterocolitis
58 occurrence
59 part
60 pathogenesis
61 patients
62 standard of care
63 standards
64 system
65 schema:name Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin
66 schema:pagination 351-355
67 schema:productId N59b3d44b1bde41178ec668ba1afa9c6f
68 Nb51d689ffadf434ba03f5f1508eb3e33
69 Nca1614331444413ebac9f3c678e1fbf0
70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110337576
71 https://doi.org/10.1007/s12185-018-2558-4
72 schema:sdDatePublished 2022-11-24T21:03
73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
74 schema:sdPublisher N57c1e33b87e84feb9d1a6503f76d00cb
75 schema:url https://doi.org/10.1007/s12185-018-2558-4
76 sgo:license sg:explorer/license/
77 sgo:sdDataset articles
78 rdf:type schema:ScholarlyArticle
79 N01fae2deaa54438682a0828a06dd9c47 schema:issueNumber 3
80 rdf:type schema:PublicationIssue
81 N0ce2b6bad3184977be1b455336f9e7bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Staurosporine
83 rdf:type schema:DefinedTerm
84 N165adc9c979d40308d490be267111bfb rdf:first sg:person.01037220762.97
85 rdf:rest rdf:nil
86 N21aa443c199846018f8d813d7c582915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Enterocolitis, Neutropenic
88 rdf:type schema:DefinedTerm
89 N57c1e33b87e84feb9d1a6503f76d00cb schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 N59b3d44b1bde41178ec668ba1afa9c6f schema:name dimensions_id
92 schema:value pub.1110337576
93 rdf:type schema:PropertyValue
94 N6555dc42bbc5482dacbd561f553642ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Adult
96 rdf:type schema:DefinedTerm
97 N689d811e42fc4bfd942ebec39714e70f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Aged
99 rdf:type schema:DefinedTerm
100 N749e733e0555485a9498f8c20c909002 rdf:first sg:person.012047320155.05
101 rdf:rest Na8b9ee950d4a4005af7cac46b415ede5
102 N762cbe382915437f8f9e75a529f757e8 rdf:first sg:person.01362136207.47
103 rdf:rest N749e733e0555485a9498f8c20c909002
104 N76ece461d9ed4826bd1018bdbd795697 schema:affiliation grid-institutes:grid.259676.9
105 schema:familyName Petryna
106 schema:givenName Ellen
107 rdf:type schema:Person
108 N7dc004d3e02c492ca675ccc0813e85b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Male
110 rdf:type schema:DefinedTerm
111 N81a2d03e967542b69213a8155c4cfcdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name fms-Like Tyrosine Kinase 3
113 rdf:type schema:DefinedTerm
114 N8edbab97901f4685a42b7eeb402452de schema:volumeNumber 109
115 rdf:type schema:PublicationVolume
116 N93a19fc33fcd47a9b7e7700388a71de6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Middle Aged
118 rdf:type schema:DefinedTerm
119 N96d4bcbf0f2b40299fe137d2e1a3332f rdf:first sg:person.012156670311.81
120 rdf:rest N165adc9c979d40308d490be267111bfb
121 Na8b9ee950d4a4005af7cac46b415ede5 rdf:first N76ece461d9ed4826bd1018bdbd795697
122 rdf:rest N96d4bcbf0f2b40299fe137d2e1a3332f
123 Nb51d689ffadf434ba03f5f1508eb3e33 schema:name doi
124 schema:value 10.1007/s12185-018-2558-4
125 rdf:type schema:PropertyValue
126 Nc08a115a78ee4c238c49fb85cd874b97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Leukemia, Myeloid, Acute
128 rdf:type schema:DefinedTerm
129 Nca1614331444413ebac9f3c678e1fbf0 schema:name pubmed_id
130 schema:value 30506467
131 rdf:type schema:PropertyValue
132 Ndefcdf03031d427d8edf225456043505 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Humans
134 rdf:type schema:DefinedTerm
135 Ne6d7f296e4f94d9da7ea64beb72bde9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Induction Chemotherapy
137 rdf:type schema:DefinedTerm
138 Nf8527d12c9bd42faae348c3989279745 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Female
140 rdf:type schema:DefinedTerm
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
145 schema:name Oncology and Carcinogenesis
146 rdf:type schema:DefinedTerm
147 sg:journal.1076985 schema:issn 0925-5710
148 1865-3774
149 schema:name International Journal of Hematology
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01037220762.97 schema:affiliation grid-institutes:grid.259676.9
153 schema:familyName Alsharedi
154 schema:givenName Mohamed
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037220762.97
156 rdf:type schema:Person
157 sg:person.012047320155.05 schema:affiliation grid-institutes:grid.259676.9
158 schema:familyName Elhamdani
159 schema:givenName Adee
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012047320155.05
161 rdf:type schema:Person
162 sg:person.012156670311.81 schema:affiliation grid-institutes:grid.259676.9
163 schema:familyName Jamil
164 schema:givenName Muhammad Omer
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012156670311.81
166 rdf:type schema:Person
167 sg:person.01362136207.47 schema:affiliation grid-institutes:grid.259676.9
168 schema:familyName Dotson
169 schema:givenName Jennifer
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362136207.47
171 rdf:type schema:Person
172 grid-institutes:grid.259676.9 schema:alternateName Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA
173 schema:name Department of Hematology and Oncology, Marshall University, 1400 Hal Greer Blvd, 25701, Huntington, WV, USA
174 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...